Concomitant Dosimetry During Radionuclide Peptide Therapy with 177-Lu-DOTA-tate and 177-Lu-Lanreotide

被引：0
|
作者：
Heute, D. R. [1 ]
Dobrozemsky, G. [1 ]
Traub, T. [1 ]
Warwitz, B. [1 ]
von Guggenberg, E. [1 ]
Gabriel, M. [1 ]
Virgolini, I. [1 ]
机构：
[1] Med Univ Innsbruck, A-6020 Innsbruck, Austria
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2005年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S202 / S202
页数：1
相关论文
共 50 条
  • [11] Overcoming nephrotoxicity in peptide receptor radionuclide therapy using [177Lu]Lu-DOTA-TATE for the treatment of neuroendocrine tumours
    Geenen, Lorain
    Nonnekens, Julie
    Konijnenberg, Mark
    Baatout, Sarah
    De Jong, Marion
    Aerts, An
    NUCLEAR MEDICINE AND BIOLOGY, 2021, 102 : 1 - 11
  • [12] Induction and Maintenance Regimen with Peptide Receptor Radionuclide Therapy (PRRT) Lu-177-DOTA-TATE (Lu-177) in Patients with Advanced Neuroendocrine Tumours (NET)
    Mc Ewan, A.
    Wieler, M.
    Makis, W.
    McMullen, T.
    Morrish, D.
    MacLeod, S.
    Schrader, L.
    Sawyer, M.
    NEUROENDOCRINOLOGY, 2016, 103 : 94 - 94
  • [13] Microfluidic synthesis of [177Lu]Lu-DOTA-TATE
    Liu, Zheng
    Schaap, Kevin
    Rohde, Martin
    Oehlke, Elisabeth
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2017, 60 : S462 - S462
  • [14] Current Practice in Reporting Internal Dosimetry for [177Lu]Lu-DOTA-TATE Therapy: Literature Review
    Ivashchenko, O.
    O'Doherty, J.
    Perez, T.
    Tran-Gia, J.
    Hippelainen, E.
    Sandstrom, M.
    Stokke, C.
    Glatting, G.
    Cremonesi, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S368 - S368
  • [15] Peptide Receptor Radionuclide Therapy with [177Lu]Lu-DOTA-TATE in Patients with Advanced GEP NENS: Present and Future Directions
    del Olmo-Garcia, Maria I.
    Prado-Wohlwend, Stefan
    Bello, Pilar
    Segura, Angel
    Merino-Torres, Juan F.
    CANCERS, 2022, 14 (03)
  • [16] Lu-177 DOTA-TATE for peptide receptor Radionuclide therapy (PRRT): Organ, tumor, and blood kinetics
    Wehrmann, C.
    Senftleben, S.
    Baum, R. P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S358 - S359
  • [17] Serial Dosimetry in Peptide Receptor Radionuclide Therapy using Lu-177 DOTATATE or Lu-177 DOTATOC in the same Patient
    Schuchardt, C.
    Kulkarni, H.
    Baum, R. P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S139 - S139
  • [18] Dosimetry in peptide receptor radionuclide therapy (PRRNT): comparative results using Lu-177 DOTA-TATE, DOTA-NOC und DOTA-TOC
    Schuchardt, C.
    Baum, R. P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S244 - S244
  • [19] Repeated cycles of peptide receptor radionuclide therapy (PRRT) - Results and side-effects of the radioisotope 90Y-DOTA TATE, 177Lu-DOTA TATE or 90Y/177Lu-DOTA TATE therapy in patients with disseminated NET
    Pach, Dorota
    Sowa-Staszczak, Anna
    Kunikowska, Jolanta
    Krolicki, Leszek
    Trofimiuk, Malgorzata
    Stefanska, Agnieszka
    Tomaszuk, Monika
    Glowa, Boguslaw
    Mikolajczak, Renata
    Pawlak, Dariusz
    Jabrocka-Hybel, Agata
    Hubalewska-Dydejczyk, Alicja B.
    RADIOTHERAPY AND ONCOLOGY, 2012, 102 (01) : 45 - 50
  • [20] Radiopharmaceutical formulation and preliminary clinical dosimetry of [177Lu]Lu-DOTA-MGS5 for application in peptide receptor radionuclide therapy
    Zavvar, Taraneh Sadat
    Hoermann, Anton Amadeus
    Konijnenberg, Mark
    Kraihammer, Martin
    Mair, Christian
    Kronthaler, Ariane
    Joosten, Lieke
    Laverman, Peter
    Gruber, Leonhard
    di Santo, Gianpaolo
    Decristoforo, Clemens
    Virgolini, Irene
    von Guggenberg, Elisabeth
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2025, 52 (04) : 1321 - 1331
12345